Patents Assigned to AntiOp, Inc.
  • Intranasal naloxone compositions and methods of making and using same
    Patent number: 9289425
    Abstract: Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: March 22, 2016
    Assignee: AntiOp, Inc.
    Inventors: Joseph Wyse, Michael Paul DeHart
  • Intranasal naloxone compositions and methods of making and using same
    Patent number: 9192570
    Abstract: Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: November 24, 2015
    Assignee: AntiOp, Inc.
    Inventors: Joseph Wyse, Michael Paul DeHart